Volume 54, Issue 4, Pages (October 1998)

Slides:



Advertisements
Similar presentations
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Advertisements

Volume 65, Issue 6, Pages (June 2004)
Long-term evolution of cardiomyopathy in dialysis patients
Beta blockers in the management of chronic kidney disease
Plasma sodium and hypertension
Volume 70, Issue 8, Pages (October 2006)
Volume 70, Issue 3, Pages (August 2006)
Anemia management in chronic kidney disease
Volume 57, Issue 6, Pages (June 2000)
Volume 58, Issue 4, Pages (October 2000)
Volume 56, Pages S54-S56 (July 1999)
Determinants of phosphorus mobilization during hemodialysis
Volume 63, Issue 6, Pages (June 2003)
Volume 63, Issue 1, Pages (January 2003)
Peripheral microvascular parameters in the nephrotic syndrome
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Volume 68, Issue 4, Pages (October 2005)
Volume 58, Issue 1, Pages (July 2000)
Proinflammatory effects of iron sucrose in chronic kidney disease
Lipid redistribution in renal dysfunction
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Nephrology Crosswords: Hemodialysis
The epidemiology of chronic kidney disease
Gentamicin pharmacokinetics during slow daily home hemodialysis
Volume 74, Issue 8, Pages (October 2008)
Volume 61, Issue 3, Pages (March 2002)
Relationship between methylmalonic acid and cobalamin in uremia
Blood pressure targets in hemodialysis patients
Volume 61, Issue 4, Pages (April 2002)
Volume 67, Issue 1, Pages (January 2005)
Volume 19, Issue 4, Pages (September 2012)
Volume 62, Issue 2, Pages (August 2002)
Volume 65, Issue 6, Pages (June 2004)
Albumin-like material in urine
Volume 72, Issue 12, Pages (December 2007)
Watermelon stomach in a uremia patient
Volume 54, Issue 3, Pages (September 1998)
Bone mass evolution after renal transplantation
The third World Kidney Day: Looking back and thinking forward
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Alternate-day dialysis may be needed for hemodialysis patients
AGEs in foods: Do they play a role in uremia?
Long-term evolution of cardiomyopathy in dialysis patients
Volume 67, Issue 4, Pages (April 2005)
Nitric oxide inhibits the formation of advanced glycation end products
Volume 63, Issue 6, Pages (June 2003)
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Volume 61, Issue 2, Pages (February 2002)
Volume 54, Issue 4, Pages (October 1998)
Steven J. Harper, Charles R.V. Tomson, David O. Bates 
Volume 55, Issue 5, Pages (May 1999)
Daily nocturnal home hemodialysis
Volume 63, Issue 6, Pages (June 2003)
Current status of maintenance hemodialysis in Beijing, China
Organ transplantation goes to the movies
Volume 70, Issue 8, Pages (October 2006)
Volume 62, Issue 4, Pages (October 2002)
Volume 63, Issue 3, Pages (March 2003)
Volume 80, Issue 10, Pages (November 2011)
Volume 60, Issue 6, Pages (December 2001)
Volume 70, Issue 7, Pages (October 2006)
Charles A. Herzog  Kidney International 
Volume 70, Issue 5, Pages (September 2006)
The Authors Reply: Kidney International
The International Pediatric Peritonitis Registry: Starting to walk
Antioxidant therapy in hemodialysis patients: a systematic review
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Volume 54, Issue 4, Pages 1290-1295 (October 1998) Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?  Toshio Miyata, Min-Xin Fu, Kiyoshi Kurokawa, Charles van Ypersele De Strihou, Suzanne R. Thorpe, John W. Baynes  Kidney International  Volume 54, Issue 4, Pages 1290-1295 (October 1998) DOI: 10.1046/j.1523-1755.1998.00093.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Plasma Nε-(carboxymethyl)lysine (CML), pentosidine, and MDA-lysine levels in normal and hemodialysis subjects. CML (A), pentosidine (B), and malondialdehyde (MDA)-lysine (C) levels in acid hydrolysates of plasma from normal subjects (Group I, N = 9), non-diabetic hemodialysis patients (Group II, N = 25), and diabetic hemodialysis patients (Group III, N = 21), were determined by GC/MS or HPLC assay (detailed in Methods section). Data are expressed as means ± sd.*P < 0.0001 versus normal subjects. NS is not significant. Kidney International 1998 54, 1290-1295DOI: (10.1046/j.1523-1755.1998.00093.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 (A) Correlation between plasma CML and fructoselysine in hemodialysis patients. Plasma CML levels were not correlated with those of fructoselysine in hemodialysis subjects (N = 46, r = 0.186, P = 0.216). The equation of the line is y = 3.022x + 2.345. (B) Correlation between plasma CML and pentosidine in hemodialysis patients. Plasma CML levels were correlated with those of pentosidine in hemodialysis subjects (N = 46, r = 0.430, P < 0.01). The equation of the line is y = 34.86x + 1.07. Kidney International 1998 54, 1290-1295DOI: (10.1046/j.1523-1755.1998.00093.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 (A) Correlation between plasma pentosidine and MDA-lysine in hemodialysis patients. Plasma pentosidine levels were not correlated with those of MDA-lysine in hemodialysis subjects (N = 46, r = 0.097, P = 0.522). The equation of the line is y = 0.00013x + 0.033. (B) Correlation between plasma CML and MDA-lysine in hemodialysis patients. Plasma CML levels were correlated with those of MDA-lysine in hemodialysis subjects (N = 46, r = 0.320, P < 0.05). The equation of the line is y = 0.035x + 0.023. Kidney International 1998 54, 1290-1295DOI: (10.1046/j.1523-1755.1998.00093.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1290-1295DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1290-1295DOI: (10.1046/j.1523-1755.1998.00093.x) Copyright © 1998 International Society of Nephrology Terms and Conditions